Brief: SciVision Biotech to issue T$800 mln bonds secured convertible corporate bonds
Sept 30 (Reuters) - SciVision Biotech Inc 1786.TW :
* Says it will issue the first series domestic secured
convertible corporate bonds, worth up to T$800 million
* Says par value and issue price of T$100,000 for the bonds
* Says maturity period of three years and coupon rate is 0
percent for the bonds
* Says proceeds to be used for new plant establishment,
capital supplement and loan repayment
Source text in Chinese: https://goo.gl/pRkilj
Further company coverage: 1786.TW
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: jun.cao.reuters.com@reuters.net))
Recent news on Scivision Biotech
See all newsBrief: SciVision Biotech says 2017 dividend record date is June 23
Brief: SciVision Biotech scraps issuance plan of 1st overseas secured convertible corporate bonds
Brief: SciVision Biotech receives EU patent
Brief: SciVisison Biotech says no dividend for 2016
Brief: SciVision Biotech gets third category of medical materials sales license from TFDA for its products used for obstetrics and gynecology and urology